FDA approves Emoquette for prevention of pregnancy in women
Links shared publicly online about this topic.
- 462total visits
FDA approves Emoquette for prevention of pregnancy in women
View full resource at news-medical.net
Tags: Diet and Nutrition, Drug, Pharma, Women's Health, Pregnancy, FDA, News
Most Recently Shared on March 5, 2011 at 6:01 am By:
Pregnancy News: FDA approves Emoquette for prevention of pregnancy in women: Qualitest Pharmaceuticals today ann... http://bit.ly/ennjWH
Makena Drug for Pre-term Labor Out of Financial Reach for Many Pregnant Women - Parenting.com
parenting.com — “In early February, we cheered the announcement of the FDA--™s approval of Makena, the brand name of hydroxyprogesterone caproate injection, commonly known as 17P, which is a synthetic form of a hormone produced during pregnancy used to help prevent preterm births. Since the initial approval of Makena however, KV Pharmaceutical, the company that owns Makena, released the drug--™s list price, which jumped from about $10 to $20 per shot when obtained from a compounding pharmacy to a jaw” View full resource at parenting.com
Most Recently Shared on April 6, 2011 at 6:00 pm By:
Price-gouging the Makena drug for pre-term labor when a baby’s life is at risk? Not cool. http://bit.ly/gdMCLv
Price of drug to prevent preemies jumps from $20 to $1,500 after FDA approval - chicagotribune.com
chicagotribune.com — “The price of a drug used to delay birth in women at high risk of delivering prematurely is going to skyrocket following Food and Drug Administration approval of a prescription form of the product, a synthetic form of the hormone progesterone.” View full resource at chicagotribune.com
Most Recently Shared on March 10, 2011 at 2:53 am By:
FDA approves pregnancy drug; its cost jumps to $1,500: The price of a drug used to delay birth in women at high ... http://bit.ly/f3nCrx
Emoquette Approved for Oral Contraception - MPR
empr.com — “Qualitest and Endo announced that Emoquette (desogestrel and ethinyl estradiol tablets) has been approved for the prevention of pregnancy in women who elect to use oral contraceptives.” View full resource at empr.com
Most Recently Shared on March 7, 2011 at 3:55 pm By:
MPR News: Emoquette Approved for Oral Contraception: Qualitest and Endo announced that Emoquette (desogestrel an... http://bit.ly/g02s1I
Emoquette Approved for Oral Contraception - ONA
oncologynurseadvisor.com — “Qualitest and Endo announced that Emoquette (desogestrel and ethinyl estradiol tablets) has been approved for the prevention of pregnancy in women who elect to use oral contraceptives.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 7, 2011 at 3:34 pm By:
Emoquette Approved for Oral Contraception http://goo.gl/fb/9ENvr
Medical News: FDA Approves Generic Birth Control Pill - in Product Alert, OTC from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new generic oral contraceptive called Emoquette, a daily tablet that combines the hormonal compounds desogestrel and ethinyl estradiol to prevent pregnancy in wome” View full resource at medpagetoday.com
Most Recently Shared on March 5, 2011 at 4:01 pm By:
FDA Approves Generic Birth Control Pill: WASHINGTON (MedPage Today) -- The FDA has approved a… http://goo.gl/fb/AG2Et
Medical News: FDA Approves Generic Birth Control Pill - in Product Alert, OTC from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new generic oral contraceptive called Emoquette, a daily tablet that combines the hormonal compounds desogestrel and ethinyl estradiol to prevent pregnancy in wome” View full resource at medpagetoday.com
Most Recently Shared on March 4, 2011 at 11:05 pm By:
FDA Approves Makena: Progesterone Injections to Prevent Premature Birth - Parenting.com
parenting.com — “The FDA recently approved the use of hydroxyprogesterone caproate injection, commonly known as 17P, which is a synthetic form of a hormone produced during pregnancy. The drug will be marketed under the brand name Makena™ and given in weekly injections to pregnant women between 16 and 20 weeks gestation, continuing until 37 weeks. Makena is only approved for use by women who have already had a baby born before 37 weeks, and who are pregnant with one baby.” View full resource at parenting.com
Most Recently Shared on February 10, 2011 at 5:18 pm By:
FDA approves progesterone injections to prevent premature birth: http://bit.ly/gQi6BD
FDA approves KV's Makena to prevent premature labor - Related Stories - AAP SmartBrief
smartbrief.com — “KV Pharmaceutical received accelerated FDA approval for Makena to lower the risk of preterm delivery in women carrying a single fetus and who had at least one spontaneous premature birth. Makena, also known as hydroxyprogesterone caproate, is injected weekly between 16 and 37 weeks of pregnancy. <a” View full resource at smartbrief.com
Most Recently Shared on February 7, 2011 at 11:48 pm By:
FDA approves KV's Makena to prevent premature labor http://sbne.ws/r/6HHR
FDA Approval Of Progesterone Injections Welcomed By March Of Dimes
medicalnewstoday.com — “New Drug Can Reduce the Risk of Preterm Births in Some Women The first-ever drug known to prevent some preterm births, which won market approval from the Food and Drug Administrat” View full resource at medicalnewstoday.com
Most Recently Shared on February 7, 2011 at 2:02 pm By:
FDA Approval Of Progesterone Injections Welcomed By March Of Dimes http://sns.ly/cGbWy5 #pregnancy
Makena approved for prevention of preterm birth - MPR
empr.com — “Hologic announced that the FDA has approved Makena (hydroxyprogesterone caproate injection), formerly known as Gestiva, to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.” View full resource at empr.com
Most Recently Shared on February 4, 2011 at 4:17 pm By:
MPR News: Makena approved for prevention of preterm birth: Hologic announced that the FDA has approved Makena (h... http://bit.ly/fxaNcP
Makena approved for prevention of preterm birth - ONA
oncologynurseadvisor.com — “Hologic announced that the FDA has approved Makena (hydroxyprogesterone caproate injection), formerly known as Gestiva, to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 4, 2011 at 3:36 pm By:
Makena approved for prevention of preterm birth http://goo.gl/fb/TNIMO
Lo Loestrin FE oral contraceptive approved - ONA
oncologynurseadvisor.com — “Warner Chilcott announced that the FDA has approved Lo Loestrin FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets) for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 22, 2010 at 2:23 pm By:
Lo Loestrin FE oral contraceptive approved http://goo.gl/fb/Mx448
Lo Loestrin FE oral contraceptive approved - MPR
empr.com — “Warner Chilcott announced that the FDA has approved Lo Loestrin FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets) for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.” View full resource at empr.com
Most Recently Shared on October 22, 2010 at 2:18 pm By:
MPR News: Lo Loestrin FE oral contraceptive approved: Warner Chilcott announced that the FDA has approved Lo Loest... http://bit.ly/dsVGnH
Christiane Northrup, MD: Ella, Week After Birth Control Pill: A Boon for European Women, But Will It Make It to America?
huffingtonpost.com — “The FDA is studying a new morning-after pill. It is effective for preventing pregnancy up to 120 hours following unprotected sex and was approved for use in 44 countries in early 2009.” View full resource at huffingtonpost.com
Most Recently Shared on June 15, 2010 at 12:49 pm By:
Ella, Week After Birth Control Pill: A Boon for European Women, But Will It Make It to America?: The FDA is study... http://huff.to/92FtGt
Advertisement

